Comparative Pharmacology
Head-to-head clinical analysis: HYDROCODONE BITARTRATE CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDROCODONE BITARTRATE CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydrocodone: mu-opioid receptor agonist; Chlorpheniramine: histamine H1 receptor antagonist; Pseudoephedrine: sympathomimetic amine, alpha- and beta-adrenergic receptor agonist.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
1 tablet (Hydrocodone 5 mg / Chlorpheniramine 4 mg / Pseudoephedrine 60 mg) orally every 4-6 hours as needed for cough and congestion; maximum 4 tablets per day.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Hydrocodone: 3.8-6 hours; Chlorpheniramine: 14-25 hours (prolonged in children); Pseudoephedrine: 5-8 hours (pH-dependent urinary excretion).
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Hydrocodone: primarily renal (as conjugated metabolites, norhydrocodone, and unchanged drug); <5% fecal. Chlorpheniramine: renal (as metabolites, ~20% unchanged) and fecal. Pseudoephedrine: renal (>90% unchanged via active tubular secretion).
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic